Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
BioNTech
Sort By
Newest First
1 / 1
1 / 1
COVID-19 Vaccine
AGC Biologics Supports Omicron-Based Vaccine Candidate Manufacturing with Starting Material
AGC Biologics
PR-M02-22-07
Feb 09, 2022
COVID-19 Vaccine
Pfizer and BioNTech to Vaccinate Olympic Athletes in Tokyo
Pfizer
PR-M05-21-014
May 20, 2021
Emergency Use
Pfizer and BioNtech Receive First U.S. Authorization for Emergency Use of Covid-19 Vaccine in Adolescents
Pfizer
PR-M05-21-007
May 11, 2021
COVID-19
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
Pfizer
PR-M11-20-007
Nov 10, 2020
M&A
BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021
Nice Insight
PR-M09-20-28
Sep 24, 2020
COVID-19 Vaccine
Pfizer and BioNTech Announce Data from Preclinical Studies of COVID-19 Vaccine Candidate
Pfizer
PR-M09-20-NI-15
Sep 11, 2020
Collaboration
BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo Combination in Melanoma
BioNTech
PR-M08-20-NI-06
Jul 31, 2020
COVID-19 Vaccine
Pfizer and BioNTech to Receive $2 Billion from U.S. Government
Pfizer
PR-M07-20-NI-33-1383
Jul 23, 2020
COVID-19 Vaccine
Pfizer and BioNTech Report T Cell Response in COVID-19 Vaccine
Pfizer
PR-M07-20-NI-30
Jul 21, 2020
COVID-19 Vaccine
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer
PR-M06-20-NI-042
Jul 02, 2020
Vaccine
Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
BioNTech
PR-M03-20-NI-031
Mar 20, 2020
Collaboration
BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs
BioNTech
PR-M09-19-NI-033
Sep 12, 2019
Series B Financing
BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline
BioNTech
PR-M07-19-NI-025
Jul 10, 2019
Vaccine
Thermo Fisher Scientific to Support mRNA-based Vaccine Candidate Production for BioNTech
Thermo Fisher Scientific
PA2984
Feb 28, 2019
Collaboration
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
BioNTech
PR-M09-18-NI-052
Sep 18, 2018
